NRC HEALTH (NRC) Form 8-K — Apr 28, 2026
NRC Health reported financial results for the first quarter of 2026, achieving total revenue of $34.8 million, a 4% increase year-over-year. The company recorded its first quarter of year-over-year revenue growth since 2023, driven by a 13% increase in Total Recurring Contract Value (TRCV) to $152.1 million. The Board of Directors declared a quarterly cash dividend of $0.16 per share, payable on July 10, 2026, to shareholders of record as of June 26, 2026. CEO Trent Green highlighted the signing of the largest deal in the company's 45-year history as validation of its strategy, noting that new sales and customer retention reached multi-year highs.
Key figures
- Eps
- 0.14
- Revenue
- 34803000
- Revenue Yoy
- 4%
- Trcv
- 152.1 million
- Trcv Growth
- 13%
- Adjusted Eps
- 0.21
- Dividend Per Share
- 0.16
Price after filing
Close on the filing date to close N calendar days later (from $16.84). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.